Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity.

Logsdon BC, Vickrey JF, Martin P, Proteasa G, Koepke JI, Terlecky SR, Wawrzak Z, Winters MA, Merigan TC, Kovari LC.

J Virol. 2004 Mar;78(6):3123-32.

2.

Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.

Lefebvre E, Schiffer CA.

AIDS Rev. 2008 Jul-Sep;10(3):131-42. Review.

3.

Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.

Velazquez-Campoy A, Muzammil S, Ohtaka H, Schön A, Vega S, Freire E.

Curr Drug Targets Infect Disord. 2003 Dec;3(4):311-28. Review.

PMID:
14754432
4.

Targeting structural flexibility in HIV-1 protease inhibitor binding.

Hornak V, Simmerling C.

Drug Discov Today. 2007 Feb;12(3-4):132-8. Epub 2006 Dec 20. Review.

5.

Inhibitors of HIV proteinase.

Martin JA, Redshaw S, Thomas GJ.

Prog Med Chem. 1995;32:239-87. Review. No abstract available.

PMID:
8577919
6.

Tackling the problem of HIV drug resistance.

Weber IT, Harrison RW.

Postepy Biochem. 2016;62(3):273-279. Review.

Supplemental Content

Support Center